Eurythmy Therapy for Dry Mouth

Erdmuthe Worel, Eurythmy Therapy Team Klinik Arlesheim, Andreas Worel

Last update: 14.08.2019

The therapeutic aim in the treatment of dry mouth is to stimulate the etheric body through exercises that specifically affect the fluid organism. Additional appropriate movements enable the soul body and ‘I’-organization to better reconnect with the etheric body, stimulating glandular activity.

Therapeutic recommendations

  • “M” and “L” in a rocking step  
    A rocking step with “M” and “L” stimulates the etheric body which is active in the fluid organism.
    The gestures for “M” and “L” can also be done with the feet, standing or sitting. Stimulating rhythms such as iamb and anapest set the fluid organism in motion.

  • The sound “R”
    The ‘air sound’ “R” sets the soul body in motion and strengthens its connection with the physical and etheric bodies, thereby stimulating glandular activity.

  • “CH” and “F” or “W” in alternation
    Sounds such as “CH” and either “F” or “W” in alternation connect the front with the back space as in a wave. They stimulate the flow of body fluids, also counteracting the feelings of constriction through their gesture of widening.
    In bedridden patients, we can guide “CH” alternately with “F” or “W” around the mouth or from the mouth to the periphery, as this diverts or eases the experienced fixation on the problem.

  • Direct “H” into a widening “A” and ebb down with “SCH”.

  • Hands and feet in motion
    Moving the hands and feet, either actively or passively by the eurythmy therapist, has a relaxing effect. It stimulates the etheric body in the fluid organism.

Research news

Phase IV trial: Kalium phosphoricum comp. versus placebo in irritability and nervousness 
In a new clinical study, Kalium phosphoricum comp. (KPC) versus placebo was tested in 77 patients per group. In a post-hoc analysis of intra-individual differences after 6 weeks treatment, a significant advantage of KPC vs. placebo was shown for characteristic symptoms of nervous exhaustion and nervousness (p = 0.020, p = 0.045 respectively). In both groups six adverse events (AE) were assessed as causally related to treatment (severity mild or moderate). No AE resulted in discontinuation in treatment. KPC could therefore be a beneficial treatment option for symptomatic relief of neurasthenia. The study has been published open access in Current Medical Research and Opinion
https://doi.org/10.1080/03007995.2023.2291169.


Further information on Anthroposophic Medicine